Professor Sir Peter Horby responds to the UK Covid-19 Inquiry's Module 1 report published today, which focuses on the UK's pandemic resilience and preparedness.
Launch of UK trial is major milestone in developing a vaccine against Marburg virus \u2013 a highly virulent disease that is fatal in up to 88% of cases.
Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.
Professor Sir Peter Horby has been elected as a Fellow of the Royal Society, joining a cohort of the world\u2019s most eminent scientists, engineers and technologists who have made substantial contributions to the advancement of science.
Whether new research or emerging insights on current outbreaks such as mpox and H5N1, the International Pandemic Sciences Conference 2024 is inviting abstracts for presentation in our late-breaking parallel session.
A team from PSI\u2019s Policy and Practice Research Group are finalists in the University of Oxford\u2019s Vice-Chancellor Awards for outstanding research engagement.
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
Meet the presenters, panellists and chairs for the International Pandemic Sciences Conference 2024, set to take place on 1\u20132 July 2024 in Oxford and online.
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 \u2013 Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.
Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.
PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
The University of Oxford has launched a new global vaccine collaboration, backed by \u00a38 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
Professor Dame Sarah Gilbert, the Oxford Project Leader for the Oxford-AstraZeneca COVID-19 vaccine and Pandemic Sciences Institute researcher, has received the Freedom of the City of London in recognition of her outstanding achievements in, and contribution to, science and public health.
The UK trial is the next step in the development of a vaccine to protect people against MERS \u2013 a deadly viral illness with no current vaccines and the potential to cause a pandemic.
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
![\"Peter](\"https://www.psi.ox.ac.uk/news-and-opinion/psi-director-comments-on-uk-covid-19-inquiry-module-1-report/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n